Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 1472708, 2 pages
https://doi.org/10.1155/2018/1472708

Editorial

Antioxidants and Prooxidants: Effects on Health and Aging

Márcio Carocho,¹ Isabel C. F. R. Ferreira,¹ Patricia Morales,² and Marina Soković³

¹Mountain Research Centre (CIMO), Polytechnic Institute of Bragança, Bragança, Portugal
²Complutense University of Madrid, Madrid, Spain
³University of Belgrade, Belgrade, Serbia

Correspondence should be addressed to Márcio Carocho; mcarocho@ipb.pt

Received 18 October 2017; Accepted 18 October 2017; Published 28 February 2018

Copyright © 2018 Márcio Carocho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reactive species are compounds related to two types of molecules, the reactive oxygen species and the reactive nitrogen species. These compounds are produced in the normal metabolism of cells and may take part in the pathological process named oxidative stress, which is promoted when the balance between free radicals and antioxidants tends to favour the former. As a result, the excess of free radicals within the human body leads to oxidative stress, resulting in the development or potentiation of many types of diseases, namely, chronic disorders, cardiovascular problems, diabetes, cancer, and rheumatoid arthritis [1].

A few decades ago, the belief regarding free radicals and oxidative stress was that they were completely undesired and dangerous for the human body and needed to be removed from our bodies immediately after their formation, either through endogenous or exogenous (diet) antioxidants. Today, this demonizing view has mellowed down and it is known that oxidative stress is part of the innate human immune system, and that free radicals are also related to defence mechanisms, but also used as cell mediators, pathway signalling, cell differentiation, proliferation and migration inducers, and release or inactivate the endothelium-derived relaxing factor, among other processes [1, 2].

The aim of this special edition is to shed some light on the effects of antioxidants and prooxidants on diseases and their overall impact on aging, following the free radical theory of aging. The initial focus of aging was centred on the free radical damage to macromolecules; however, it has become clear that hydroperoxides like H₂O₂ play important roles in physiologic signalling. Thus, the dichotomy resides on the fact that alterations in redox signalling are observed in aging, but, on the other hand, deviation from redux homeostasis can result in disease, making the study of redox signalling a hot topic. Furthermore, the free radical theory of aging has been threatened after recent discoveries on the importance of hydroperoxides and other radicals in the human body. Many scientists claim that it is should not be considered a single theory, but a part of a wider general theory of aging [3, 4]. Despite the free radical theory of aging being questioned, the link between free radicals, oxidative stress, and many diseases is scientifically proven. Examples of these diseases are neurodegenerative ones, which, with increasing life expectancy will also increase in the coming decades. New and unusual methods are being tested for these types of diseases, namely, by fine-tuning antioxidant concentrations, exhaustive study of antioxidant mechanisms and interactions, modulation of oxidative stress, and other therapeutic approaches [5–7].

This special edition, comprised of 9 original research articles and 4 reviews on various aspects, namely, pro and antioxidant functions of the peroxisome-mitochondria connection and its impact on aging and disease, the impact of oxidative stress on the regeneration of pancreatic beta cells, the impact of metallothionein in brain disorders, and finally an extensive overview of the role of flavonoids as putative inducers of transcription factors Nrf2, FoxO, and PPARγ. In terms of research manuscripts, four of these describe the role of specific plant compounds in the human body or in test subjects (mice and rats), namely, the cardioprotective effects of salvianic acid A and raloxifene in mice with elevated homocysteine and estrogen-deficient rats, respectively. The effects of berberine as preconditioning agent to reduce premature senescence of cells were also researched, as well as the effect of resveratrol on rats’ cognitive performance with aging. Plant extracts were also described as having cardioprotective effects and reducing oxidative stress, while the in vitro antioxidant and antifibrotic profile of other herbal formulations was tested. Dietary supplements, commonly reported as being effective against many neurodegenerative diseases and having antioxidant activity, were also tested in terms of quality control by liquid chromatography with the aid of a mass spectrometer. Finally, using new agar diffusion methods, the risk of tumors was evaluated through the measurement of urinary and serumal antioxidants.

The editors hope that the published articles of this special edition may be of interest to all readers, and overall, be of aid to further improve the research on free radicals, antioxidants and prooxidants, aging, and related diseases.

Acknowledgments

We would like to thank the editorial staff for the help during the whole extension of the preparation of the special edition, but also to the kind reviewers that anonymously contributed to improving the manuscripts. A word of appreciation to all authors that chose to submit their works to this special edition. We hope readers enjoy the latest developments that are published in this special edition.

Márcio Carocho
Isabel C. F. R. Ferreira
Patricia Morales
Marina Soković

References

I. Mirończuk-Chodakowska, A. M. Witkowska, and M. E. Zujko, “Endogenous non-enzymatic antioxidants in the human body,” Advances in Medical Sciences, vol. 63, no. 1, pp. 68–78, 2018.

M. Carocho and I. C. F. R. Ferreira, “A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives,” Food and Chemical Toxicology, vol. 51, pp. 15–25, 2013.

S. I. Liochev, “Reactive oxygen species and the free radical theory of aging,” Free Radical Biology & Medicine, vol. 60, pp. 1–4, 2013.

H. J. Forman, “Redox signaling: an evolution from free radicals to aging,” Free Radical Biology & Medicine, vol. 97, pp. 398–407, 2016.

S. Losada-Barreiro and C. Bravo-Díaz, “Free radicals and polyphenols: the redox chemistry of neurodegenerative diseases,” European Journal of Medicinal Chemistry, vol. 133, pp. 379–402, 2017.

P. Poprac, K. Jomova, M. Simunkova, V. Kollar, C. J. Rhodes, and M. Valko, “Targeting free radicals in oxidative stress-related human diseases,” Trends in Pharmacological Sciences, vol. 38, no. 7, pp. 592–607, 2017.

K. A. Wojtunik-Kulesza, A. Oniszczuk, T. Oniszczuk, and M. Waksmundzka-Hajnos, “The influence of common free radicals and antioxidants on development of Alzheimer’s disease,” Biomedicine & Pharmacotherapy, vol. 78, pp. 39–49, 2016.